Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2010
Total Assets: $38.15B
Liabilities Breakdown FY2010
Total Liabilities: $16.15B
Asset Breakdown
Total Assets: $38.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.25B | 3.3% |
| Accounts Receivable | $5.48B | 14.4% |
| Inventory | $3.87B | 10.1% |
| Property, Plant & Equipment | $4.36B | 11.4% |
| Goodwill | $15.23B | 39.9% |
| Intangible Assets | $5.75B | 15.1% |
| Other Assets | $2.22B | 5.8% |
Liabilities Breakdown
Total Liabilities: $16.15B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $4.80B | 29.7% |
| Other Liabilities | $11.35B | 70.3% |